Lee Greenberger, PhD, chief scientific officer, The Leukemia & Lymphoma Society, discusses new agents that were recently approved for multiple myeloma.
Lee Greenberger, PhD
Advertisement
Articles by Lee Greenberger, PhD
Lee Greenberger, PhD, chief scientific officer, The Leukemia & Lymphoma Society, discusses how the society contributes to blood cancer research.
Advertisement
Latest Updated Articles
Lee Greenberger on Newly Approved Drugs for Multiple MyelomaDecember 18th 2015
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Tregzi for Chronic GVHD-Free Survival in Blood Cancer
2
FDA Approves Ready-to-Use Aprepitant Injectable Emulsion for CINV
3
Accelerated Biological Aging Linked to Rising Early-Onset Cancer Risk
4
Mogamulizumab Improves Quality of Life in Real-World MF and SS Study
5